Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2016		Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Net Sales	$ 12,483		$ 12,036	$ 35,138	$ 37,316
Cost of sales	9,841		9,349	27,067	29,030
Research and development expenses	399		382	1,159	1,194
Selling, general and administrative expenses	864		689	2,393	2,214
Amortization of intangibles	162		105	387	316
Restructuring charges	0		0	452	375
Equity in earnings of nonconsolidated affiliates	70		135	191	575
Sundry income (expense) - net	(4)		632	1,305	1,680
Interest income	26		18	64	46
Interest expense and amortization of debt discount	220		233	629	706
Income Before Income Taxes	1,089		2,063	4,611	5,782
Provision for income taxes	271		627	291	1,630
Net Income	818		1,436	4,320	4,152
Net income attributable to noncontrolling interests	14		61	54	79
Net Income Attributable to The Dow Chemical Company	804		1,375	4,266	4,073
Preferred stock dividends	85	[1]	85	255	255
Net Income Available for The Dow Chemical Company Common Stockholders	$ 719		$ 1,290	$ 4,011	$ 3,818
Per Common Share Data:
Earnings per common share - basic	$ 0.64		$ 1.12	$ 3.60	$ 3.33
Earnings per common share - diluted	0.63		1.09	3.48	3.24
Dividends declared per share of common stock	$ 0.46		$ 0.42	$ 1.38	$ 1.26
Weighted-average common shares outstanding - basic	1,112.4		1,141.3	1,108.8	1,138.4
Weighted-average common shares outstanding - diluted	1,127.4		1,250.6	1,220.4	1,248.9
Depreciation	$ 573		$ 494	$ 1,540	$ 1,463
Capital Expenditures	$ 1,060		$ 916	$ 2,877	$ 2,817

[1] Preferred stock dividends were not added back in the calculation of diluted earnings per share for the three months ended September 30, 2016, because the effect of adding them back would have been antidilutive.